12-95973615-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002108.4(HAL):c.*617G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.029 in 153,054 control chromosomes in the GnomAD database, including 103 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 102 hom., cov: 32)
Exomes 𝑓: 0.027 ( 1 hom. )
Consequence
HAL
NM_002108.4 3_prime_UTR
NM_002108.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.159
Genes affected
HAL (HGNC:4806): (histidine ammonia-lyase) Histidine ammonia-lyase is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. Histidine ammonia-lyase defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluids. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 12-95973615-C-T is Benign according to our data. Variant chr12-95973615-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 310689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.029 (4421/152242) while in subpopulation NFE AF= 0.0433 (2946/68004). AF 95% confidence interval is 0.042. There are 102 homozygotes in gnomad4. There are 2213 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 102 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HAL | NM_002108.4 | c.*617G>A | 3_prime_UTR_variant | 21/21 | ENST00000261208.8 | NP_002099.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HAL | ENST00000261208.8 | c.*617G>A | 3_prime_UTR_variant | 21/21 | 1 | NM_002108.4 | ENSP00000261208 | P1 | ||
HAL | ENST00000541929.5 | c.*617G>A | 3_prime_UTR_variant | 20/20 | 2 | ENSP00000446364 | ||||
HAL | ENST00000544080.6 | downstream_gene_variant | 2 | ENSP00000439385 |
Frequencies
GnomAD3 genomes AF: 0.0291 AC: 4428AN: 152124Hom.: 103 Cov.: 32
GnomAD3 genomes
AF:
AC:
4428
AN:
152124
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0271 AC: 22AN: 812Hom.: 1 Cov.: 0 AF XY: 0.0224 AC XY: 10AN XY: 446
GnomAD4 exome
AF:
AC:
22
AN:
812
Hom.:
Cov.:
0
AF XY:
AC XY:
10
AN XY:
446
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0290 AC: 4421AN: 152242Hom.: 102 Cov.: 32 AF XY: 0.0297 AC XY: 2213AN XY: 74442
GnomAD4 genome
AF:
AC:
4421
AN:
152242
Hom.:
Cov.:
32
AF XY:
AC XY:
2213
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
111
AN:
3468
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Histidinemia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at